Rubric Capital Management LP
Q3 2023 13F-HR/A Holdings
Net value change ($000)
+327,386
(14.0%)
New positions
9
Sold out positions
11
Turnover %
18.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| BGC | 105,600 | NEW |
| ROIV | 86,993 | 244.0% |
| TEVA | 52,851 | 37.5% |
| GOLAR LNG LTD | 27,621 | 21.2% |
| NRG | 25,045 | 97.4% |
| QDEL | 21,651 | NEW |
| Revance Therapeutics, Inc. | 18,352 | NEW |
| CCJ | 15,599 | 18.5% |
| MSGS | 14,723 | NEW |
| PCRX | 14,102 | NEW |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
286,985
(10.8% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|